Cancer Metastasis Laboratory, Department of Biomedicine, University of Basel and University Hospital Basel, 4058 Basel, Switzerland.
Cancer Metastasis Laboratory, Department of Biomedicine, University of Basel and University Hospital Basel, 4058 Basel, Switzerland; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
Cell. 2019 Jan 10;176(1-2):98-112.e14. doi: 10.1016/j.cell.2018.11.046.
The ability of circulating tumor cells (CTCs) to form clusters has been linked to increased metastatic potential. Yet biological features and vulnerabilities of CTC clusters remain largely unknown. Here, we profile the DNA methylation landscape of single CTCs and CTC clusters from breast cancer patients and mouse models on a genome-wide scale. We find that binding sites for stemness- and proliferation-associated transcription factors are specifically hypomethylated in CTC clusters, including binding sites for OCT4, NANOG, SOX2, and SIN3A, paralleling embryonic stem cell biology. Among 2,486 FDA-approved compounds, we identify Na/K ATPase inhibitors that enable the dissociation of CTC clusters into single cells, leading to DNA methylation remodeling at critical sites and metastasis suppression. Thus, our results link CTC clustering to specific changes in DNA methylation that promote stemness and metastasis and point to cluster-targeting compounds to suppress the spread of cancer.
循环肿瘤细胞 (CTC) 形成簇的能力与增加的转移潜能有关。然而,CTC 簇的生物学特征和脆弱性在很大程度上仍然未知。在这里,我们在全基因组范围内对来自乳腺癌患者和小鼠模型的单个 CTC 和 CTC 簇进行了 DNA 甲基化图谱分析。我们发现,与干性和增殖相关的转录因子的结合位点在 CTC 簇中特异性低甲基化,包括 OCT4、NANOG、SOX2 和 SIN3A 的结合位点,与胚胎干细胞生物学相似。在 2486 种 FDA 批准的化合物中,我们确定了 Na/K ATPase 抑制剂,它可以使 CTC 簇解离成单个细胞,导致关键部位的 DNA 甲基化重塑和转移抑制。因此,我们的研究结果将 CTC 聚类与促进干性和转移的特定 DNA 甲基化变化联系起来,并指出了针对聚类的化合物,以抑制癌症的扩散。